Attention Deficit Disorder with Hyperactivity: all 1,547 studies

Page 4 of 16. Open to participants first (254), then studies with results posted, then the rest; newest registration first within each.

• Development of a Mobile App for an Executive Functioning Intervention for AdolescentsCompletedNCT04018794Not applicableResults posted
• Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHDCompletedNCT04016779Phase 3Results posted
• Study of the Duration and Efficacy of MYDAYIS on Adult ADHD Symptoms and Executive Function Throughout the Day Into the Early EveningCompletedNCT03945175Phase 3Results posted
• 12 Month Open Extension of TNS for ADHD.CompletedNCT03888391Not applicableResults posted
• Four-week Open-trial Extension TNS for ADHDCompletedNCT03870737Not applicableResults posted
• Electroencephalogram (EEG) Study of Inattention Following Treatment With AKL-T01CompletedNCT03844269Not applicableResults posted
• A SMART Design to Improve Sleep Disturbance in Adolescents With Neurodevelopmental DisordersCompletedNCT03730194Not applicableResults posted
• Lifestyle Enhancement for ADHD ProgramCompletedNCT03690674Not applicableResults posted
• Prevalence of Lidocaine Ineffectiveness in Adults With and Without ADHDCompletedNCT03676725Early Phase 1Results posted
• Transcranial Magnetic Stimulation for Attention Deficit/Hyperactivity Disorder (ADHD)CompletedNCT03663179Not applicableResults posted
• Adult Attention Deficit Hyperactivity Disorder (ADHD) Study With Amphetamine SulfateCompletedNCT03659929Phase 3Results posted
• Software Treatment for Actively Reducing Severity of ADHD as Adjunctive Treatment to StimulantCompletedNCT03649074Not applicableResults posted
• Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With ADHDTerminatedNCT03638466Phase 2Results posted
• Pharmacokinetic Study of DYANAVEL XR (Amphetamine) Extended-release Oral Suspension, in Children Aged 4 to 5 YearsCompletedNCT03610464Phase 4Results posted
• PART B: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and Without mGluR MutationsCompletedNCT03609619Phase 2Results posted
• A Trial Evaluating the Long-term Safety and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-Deficit/Hyperactivity DisorderCompletedNCT03605849Phase 3Results posted
• A Trial to Evaluate the Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity DisorderCompletedNCT03605836Phase 3Results posted
• A Trial Evaluating the Efficacy, Safety, & Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity DisorderCompletedNCT03605680Phase 3Results posted
• Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD TreatmentTerminatedNCT03597503Phase 3Results posted
• Efficacy of Lisdexamfetamine Dimesylate for Promoting Occupational Success in Young Adults With ADHDCompletedNCT03446885Phase 4Results posted
• Food Additives Effects on EEG Profiles in College Students With ADHDCompletedNCT03342469Not applicableResults posted
• Safety, Tolerability and Pharmacokinetics of SHP465 in Children Aged 4 to 5 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedNCT03327402Phase 1Results posted
• Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD)TerminatedNCT03325894Phase 3Results posted
• Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 YearsCompletedNCT03325881Phase 3Results posted
• The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity DisorderCompletedNCT03324581Phase 2Results posted
• Neurophysiological Markers of Pediatric Irritability and Its Response to InterventionTerminatedNCT03279952Phase 4Results posted
• PART A: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and With mGluR MutationsCompletedNCT03265119Phase 2Results posted
• Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD)CompletedNCT03260205Phase 3Results posted
• Micronutrients for Attention-Deficit Hyperactivity Disorder in Youth (MADDY) StudyCompletedNCT03252522Phase 1/2Results posted
• Impact of Combined Medication and Behavioral Treatment for ASD & ADHDTerminatedNCT03242772Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.CompletedNCT03231800Phase 3Results posted
• Dyanavel® XR Extended-Release Oral Suspension in the Treatment of Children With ADHD: A Laboratory School StudyCompletedNCT03088267Phase 3Results posted
• Improving ADHD Teen DrivingCompletedNCT02848092Not applicableResults posted
• Software Treatment for Actively Reducing Severity of ADHD - Follow UpCompletedNCT02828644Not applicableResults posted
• Treatment of Cannabis Use Disorder Among Adults With Comorbid Attention-Deficit/Hyperactivity DisorderCompletedNCT02803229Phase 2/3Results posted
• Efficacy and Safety of NFC-1 in Adolescents With Genetic Disorders Impacting mGluR and ADHDCompletedNCT02777931Phase 2/3Results posted
• A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.CompletedNCT02734693Phase 3Results posted
• Communication to Improve Shared Decision-Making in ADHDCompletedNCT02716324Not applicableResults posted
• Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits in ChildrenCompletedNCT02712996Phase 4Results posted
• LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for LeukodystrophiesCompletedNCT02699190Results posted
• A Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD)CompletedNCT02699086Phase 2Results posted
• Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 4)TerminatedNCT02691182Phase 3Results posted
• A Flexible-Dose Titration Study of Aptensio XR in Children Ages 4 to Under 6 Years Diagnosed With ADHDCompletedNCT02683265Phase 4Results posted
• Software Treatment for Actively Reducing Severity of ADHDCompletedNCT02674633Not applicableResults posted
• Effects of Evening Dose of Immediate Release Methylphenidate on Sleep in Children With ADHDTerminatedNCT02638168Phase 4Results posted
• Shire SCT: Lisdexamfetamine Treatment for ADHD and SCTCompletedNCT02635035Phase 2Results posted
• Efficacy and Safety of SPN-812 (Viloxazine Extended-release Capsule) in Children With ADHDCompletedNCT02633527Phase 2Results posted
• Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 2)CompletedNCT02618434Phase 3Results posted
• Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 1)CompletedNCT02618408Phase 3Results posted
• Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)CompletedNCT02604407Phase 3Results posted
• L-Threonic Acid Magnesium Salt (L-TAMS) in ADHDCompletedNCT02558790Phase 2Results posted
• Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)CompletedNCT02547428Phase 2Results posted
• PK/PD Pediatric ADHD Classroom StudyCompletedNCT02536105Not applicableResults posted
• A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Naturalistic SettingCompletedNCT02520388Phase 3Results posted
• Intervention for Teens With ADHD and Substance UseTerminatedNCT02502799Phase 3Results posted
• A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Classroom SettingCompletedNCT02493777Phase 3Results posted
• Training Attentional Awareness and Control in ADHDCompletedNCT02489279Not applicableResults posted
• Pharmacokinetic Study of Methylphenidate HCl Extended-Release Capsules in Children 4 to Under 6 Years of Age With ADHDCompletedNCT02470234Phase 4Results posted
• Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)CompletedNCT02466425Phase 3Results posted
• Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity DisorderCompletedNCT02466386Phase 3Results posted
• Dasotraline Pediatric Extension StudyCompletedNCT02457819Phase 3Results posted
• Safety, Tolerability, Pharmacokinetic, and Efficacy Study of SPD489 in Preschool Children With Attention-deficit/Hyperactivity DisorderCompletedNCT02402166Phase 2Results posted
• New Technologies to Help Manage ADHDCompletedNCT02390791Not applicableResults posted
• Investigating the Effect of Vortioxetine in Adult ADHD PatientsCompletedNCT02327013Phase 2Results posted
• The Effects of ADHD Medication (TEAM) StudyCompletedNCT02293655Phase 4Results posted
• Atomoxetine in Veterans With Comorbid ADHD/PTSDCompletedNCT02287038Phase 4Results posted
• Educating and Supporting Primary Care Providers in the Implementation of Evidence-based Practices for ADHDCompletedNCT02271386Not applicableResults posted
• An fMRI Study of Stimulant vs. Non-Stimulant Treatment of ADHDTerminatedNCT02259517Not applicableResults posted
• A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHDCompletedNCT02255513Phase 3Results posted
• Double-Blind 2-Site Randomized Clinical Trial of Neurofeedback for ADHDCompletedNCT02251743Not applicableResults posted
• Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBICompletedNCT02225106Phase 2Results posted
• Omega-3 Supplementation to ADHD Medication in ChildrenCompletedNCT02204410Phase 4Results posted
• Methylphenidate Treatment of Attention Deficits in EpilepsyCompletedNCT02178995Phase 4Results posted
• Lisdexamfetamine's Effect In ADHD in the Brain and CognitionTerminatedNCT02170298Phase 4Results posted
• Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of TAK-137 in Adults With Attention-Deficit/Hyperactivity Disorder.TerminatedNCT02163915Phase 1Results posted
• Trigeminal Nerve Stimulation for ADHDCompletedNCT02155608Not applicableResults posted
• Efficacy and Safety Eval of Guanfacine Hydrochloride in Combination With Psychostimulants in Adults (18-65).CompletedNCT02141113Phase 4Results posted
• Predictive Executive Functioning Models Using Interactive Tangible-Graphical Interface Devices in AdultsCompletedNCT02127931Not applicableResults posted
• Methylphenidate ER Liquid Formulation in Adults With ASD and ADHDCompletedNCT02096952Phase 4Results posted
• Effectiveness of the Quotient® ADHD Assessment in a System of CareTerminatedNCT02094612Not applicableResults posted
• TRI102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)CompletedNCT02083783Phase 3Results posted
• A 6 Week Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD ( Attention Deficit/Hyperactivity )CompletedNCT02059642Phase 2/3Results posted
• Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive DisorderCompletedNCT02048241Phase 4Results posted
• Examining Tolerance to CNS Stimulants in ADHDCompletedNCT02039908Phase 4Results posted
• Control of Cognition (Naltrexone, Methylphenidate, and ADHD Study (NMAS))CompletedNCT01993108Phase 4Results posted
• Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom SettingCompletedNCT01986062Phase 4Results posted
• Efficacy of GXR as Adjunctive Therapy With Psycho-stimulant on Executive Function in Children With ADHDCompletedNCT01985581Phase 4Results posted
• Cognitive ADHD Videogame Exploratory StudyCompletedNCT01943539Not applicableResults posted
• Study of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 Sustained Release (SR) in the Treatment of Adult Males With Attention-Deficit Hyperactivity DisorderCompletedNCT01939353Phase 2Results posted
• A Long Term Post-Marketing Study on the EffIcacy and Safety of Osmotic Release Oral System (OROS) Methylphenidate on the Cognitive Functions of Attention Deficit Hyperactivity Disorder (ADHD) ParticipantsCompletedNCT01933880Phase 4Results posted
• Neurobiological Basis of Response to Vyvanse in Adults With ADHD: an fMRI Study of Brain ActivationCompletedNCT01924429Phase 4Results posted
• Gene-environment Interactions and Brain Functional Connectivity in Attention Deficit Hyperactivity DisorderCompletedNCT01912352Not applicableResults posted
• Pharmacokinetics of HLD200 in Children and Adolescents With ADHDCompletedNCT01907360Phase 1/2Results posted
• Effect of Omega-3 Fatty Acid on Cortical Function in ADHDCompletedNCT01883817Phase 3Results posted
• An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.CompletedNCT01873729Phase 4Results posted
• Neuroimaging of Diet in ADHD: Phase ICompletedNCT01862484Not applicableResults posted
• Neurocognitive and Neurobiological Improvement in ADHD Children by Modification of Dietary ProteinCompletedNCT01856686Early Phase 1Results posted
• L-methylfolate Supplementation to OROS-Methylphenidate Pharmacotherapy in ADHD AdultsCompletedNCT01853280Phase 2/3Results posted
• Neurofeedback and Working Memory Training for Children and Adolescents With ADHDCompletedNCT01841151Not applicableResults posted
• NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)CompletedNCT01835548Phase 3Results posted

← Attention Deficit Disorder with Hyperactivity overview